Sun, B., Jensen, N. R., Chung, D., Yang, M., LaRue, A. C., Cheung, H. W., & Wang, Q. (2019). Synergistic effects of SHP2 and PI3K pathway inhibitors in GAB2-overexpressing ovarian cancer. Am J Cancer Res.
Chicago ZitierstilSun, Bowen, Nathaniel R. Jensen, Dongjun Chung, Meixiang Yang, Amanda C. LaRue, Hiu Wing Cheung, und Qi Wang. "Synergistic Effects of SHP2 and PI3K Pathway Inhibitors in GAB2-overexpressing Ovarian Cancer." Am J Cancer Res 2019.
MLA ZitierstilSun, Bowen, et al. "Synergistic Effects of SHP2 and PI3K Pathway Inhibitors in GAB2-overexpressing Ovarian Cancer." Am J Cancer Res 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.